Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 218 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 11 results:
Author Title Type [ Year(Desc)]
Filters: Author is Katholing, A.  [Clear All Filters]
2014
C. Martinez, Katholing, A., and Freedman, S. B., “Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study”, Thromb Haemost, vol. 112, pp. 276-86, 2014.
2015
C. Martinez, Katholing, A., Wallenhorst, C., Granziera, S., Cohen, A. T., and Freedman, S. B., “Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013”, Heart, vol. 101, pp. 1748-54, 2015.
2016
B. Freedman, Martinez, C., Katholing, A., and Rietbrock, S., “Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation”, JAMA Cardiol, vol. 1, pp. 366-8, 2016.
C. Martinez, Katholing, A., Folkerts, K., and Cohen, A. T., “Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study”, J Thromb Haemost, vol. 14, pp. 1374-83, 2016.
C. Martinez, Suissa, S., Rietbrock, S., Katholing, A., Freedman, B., Cohen, A. T., and Handelsman, D. J., “Testosterone treatment and risk of venous thromboembolism: population based case-control study”, Bmj, vol. 355, p. i5968, 2016.
C. Martinez, Katholing, A., Wallenhorst, C., and Freedman, S. B., “Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study”, Thromb Haemost, vol. 115, pp. 31-9, 2016.
2017
A. T. Cohen, Katholing, A., Rietbrock, S., Bamber, L., and Martinez, C., “Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study”, Thromb Haemost, vol. 117, pp. 57-65, 2017.
2018
C. Martinez, Katholing, A., Folkerts, K., and Rietbrock, S., “Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study”, Curr Med Res Opin, vol. 34, pp. 1985-1990, 2018.
2019
T. S. Field, Weijs, B., Curcio, A., Giustozzi, M., Sudikas, S., Katholing, A., Wallenhorst, C., Weitz, J. I., Cohen, A. T., and Martinez, C., “Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study”, Thromb Haemost, 2019.
2020
C. Martinez, Katholing, A., Wallenhorst, C., and Cohen, A. T., “Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients”, Br J Haematol, 2020.
M. Giustozzi, Curcio, A., Weijs, B., Field, T. S., Sudikas, S., Katholing, A., Wallenhorst, C., Weitz, J. I., Martinez, C., and Cohen, A. T., “Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer”, Thromb Haemost, vol. 120, pp. 847-856, 2020.
[Page last reviewed 5 January 2021]